The U.S. Food and Drug Administration officially removed propofol from its list of drugs with a supply shortage, according to the American Society of Anesthesiologists.
The drug, commonly used as an ambulatory anesthetic, is available but may take time to move through the supply chain to healthcare facilities, the FDA said in its report.
More Articles on Anesthesia:
MEDNAX Acquires Anesthesia Group of Onondaga in New York
Sagent Pharmaceuticals Recalls Anesthesia Muscle Relaxant
Anesthesia Business Consultants, iMDsoft Develop Cloud-Based Anesthesia EMR
The drug, commonly used as an ambulatory anesthetic, is available but may take time to move through the supply chain to healthcare facilities, the FDA said in its report.
More Articles on Anesthesia:
MEDNAX Acquires Anesthesia Group of Onondaga in New York
Sagent Pharmaceuticals Recalls Anesthesia Muscle Relaxant
Anesthesia Business Consultants, iMDsoft Develop Cloud-Based Anesthesia EMR